Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.

Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y.

Mod Rheumatol. 2013 Apr 8. [Epub ahead of print]

PMID:
23563508
2.

Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.

Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y.

Mod Rheumatol. 2014 Mar;24(2):258-64. doi: 10.3109/14397595.2013.854069.

PMID:
24593201
3.

Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt.

Romão VC, Santos MJ, Polido-Pereira J, Duarte C, Nero P, Miguel C, Costa JA, Bernardes M, Pimentel-Santos FM, Barcelos F, Costa L, Melo Gomes JA, Pereira da Silva JA, Cunha Branco J, Canas da Silva J, Pereira da Silva JA, Fonseca JE, Canhão H.

Biomed Res Int. 2015;2015:279890. doi: 10.1155/2015/279890. Epub 2015 Apr 27.

4.

Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.

Notario Ferreira I, Ferrer González MA, Morales Garrido P, González Utrilla A, García Sanchez A, Soto Pino MJ, Suero Rosario E, Caro Hernández C, Añón Oñate I, Pérez Albaladejo L, Cáliz Cáliz R.

Reumatol Clin. 2017 Mar - Apr;13(2):78-84. doi: 10.1016/j.reuma.2016.03.014. Epub 2016 May 10. English, Spanish.

5.

Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder.

Balogh E, Madruga Dias J, Orr C, Mullan R, Harty L, FitzGerald O, Gallagher P, Molloy M, O'Flynn E, Kelly A, Minnock P, O'Neill M, Moore L, Murray M, Fearon U, Veale DJ.

Arthritis Res Ther. 2013 Dec 24;15(6):R221. doi: 10.1186/ar4421.

6.

Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.

Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.

Arthritis Rheum. 2012 May;64(5):1316-22. doi: 10.1002/art.33506.

7.

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study.

Lee YC, Cui J, Lu B, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME, Solomon DH.

Arthritis Res Ther. 2011 Jun 8;13(3):R83. doi: 10.1186/ar3353.

8.
9.

Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.

Thiele K, Huscher D, Bischoff S, Späthling-Mestekemper S, Backhaus M, Aringer M, Kohlmann T, Zink A; German Collaborative Arthritis Centres.

Ann Rheum Dis. 2013 Jul;72(7):1194-9. doi: 10.1136/annrheumdis-2012-201821. Epub 2012 Aug 21.

PMID:
22915625
10.

Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.

Walker UA, Jaeger VK, Chatzidionysiou K, Hetland ML, Hauge EM, Pavelka K, Nordström DC, Canhão H, Tomšič M, van Vollenhoven R, Gabay C.

Rheumatology (Oxford). 2016 Feb;55(2):230-6. doi: 10.1093/rheumatology/kev297. Epub 2015 Aug 27.

PMID:
26316581
11.

Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis.

Shidara K, Nakajima A, Inoue E, Hoshi D, Sugimoto N, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H.

J Rheumatol. 2017 Feb;44(2):147-153. doi: 10.3899/jrheum.160395. Epub 2016 Dec 1.

PMID:
27909083
12.

Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.

Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, van Riel PL, van de Laar MA.

Arthritis Rheum. 2011 Oct;63(10):2865-72. doi: 10.1002/art.30494.

13.

Remission in rheumatoid arthritis: wishful thinking or clinical reality?

Sesin CA, Bingham CO 3rd.

Semin Arthritis Rheum. 2005 Dec;35(3):185-96.

PMID:
16325659
14.

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.

Tanaka Y, Hirata S, Kubo S, Fukuyo S, Hanami K, Sawamukai N, Nakano K, Nakayamada S, Yamaoka K, Sawamura F, Saito K.

Ann Rheum Dis. 2015 Feb;74(2):389-95. doi: 10.1136/annrheumdis-2013-204016. Epub 2013 Nov 28. Erratum in: Ann Rheum Dis. 2016 Jul;75(7):e46.

15.

Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort.

Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH.

Ann Rheum Dis. 2012 May;71(5):681-6. doi: 10.1136/ard.2011.154625. Epub 2011 Oct 12.

PMID:
21994234
16.

Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study.

Caporali R, Idolazzi L, Bombardieri S, Ferraccioli G, Gerli R, Govoni M, Matucci Cerinic M, Pomponio G, Salaffi F, Tirri R, Benaglio F, Bianchino L, Sarzi-Puttini P; TRUST study investigators.

Clin Exp Rheumatol. 2017 May 8. [Epub ahead of print]

PMID:
28516890
17.

ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.

Lisbona MP, Solano A, Ares J, Almirall M, Salman-Monte TC, Maymó J.

J Rheumatol. 2016 Sep;43(9):1631-6. doi: 10.3899/jrheum.150849. Epub 2016 Jul 1.

PMID:
27370881
18.

Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis "ESPOIR" cohort.

Hmamouchi I, Combe B, Fautrel B, Rincheval N, Lukas C.

Joint Bone Spine. 2014 Oct;81(5):409-15. doi: 10.1016/j.jbspin.2014.02.007. Epub 2014 Apr 2.

PMID:
24703402
19.

Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.

Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Oct;70(10):1815-21. doi: 10.1136/ard.2010.149260. Epub 2011 Aug 3.

PMID:
21813548
20.

Remission in rheumatoid arthritis: a comparison of the 2 newly proposed ACR/EULAR remission criteria with the rheumatoid arthritis disease activity index-5, a patient self-report disease activity index.

Rintelen B, Sautner J, Haindl P, Mai H, Brezinschek HP, Leeb BF.

J Rheumatol. 2013 Apr;40(4):394-400. doi: 10.3899/jrheum.120952. Epub 2013 Feb 1.

PMID:
23378466

Supplemental Content

Support Center